Literature DB >> 26868525

Macrophage migration inhibitory factor drives neutrophil accumulation by facilitating IL-1β production in a murine model of acute gout.

Izabela Galvão1, Ana Carolina Fialho Dias1, Livia Duarte Tavares2, Irla Paula Stopa Rodrigues1, Celso Martins Queiroz-Junior3, Vivian Vasconcelos Costa2, Alesandra Corte Reis3, Rene Donizeti Ribeiro Oliveira4, Paulo Louzada-Junior4, Daniele Glória Souza2, Lin Leng5, Richard Bucala5, Lirlândia Pires Sousa6, Marcelo Torres Bozza7, Mauro Martins Teixeira8, Flávio Almeida Amaral9.   

Abstract

This study evaluated the role of macrophage migration inhibitory factor in inflammation caused by monosodium urate crystals. The concentration of macrophage migration inhibitory factor was increased in synovial fluid of patients with acute gout, and there was a positive correlation between intra-articular macrophage migration inhibitory factor and IL-1β concentrations. In mice, the injection of monosodium urate crystals into the knee joint increased the levels of macrophage migration inhibitory factor in macrophages and in inflamed tissue. The injection of recombinant macrophage migration inhibitory factor into the joint of mice reproduced the inflammatory response observed in acute gout, including histologic changes, the recruitment of neutrophils, and increased levels of IL-1β and CXCL1. Importantly, the accumulation of neutrophils and the amount IL-1β in the joints were reduced in macrophage migration inhibitory factor-deficient mice when injected with monosodium urate crystals. We observed a similar effect when we blocked macrophage migration inhibitory factor with (S,R)-3-(4-hydroxyphenyl)-4,5-dihydro-5-isoxazole acetic acid or anti-macrophage migration inhibitory factor. In addition, the blockade of IL-1R and CXCR2 reduced recombinant macrophage migration inhibitory factor-induced neutrophil recruitment. Mechanistically, recombinant macrophage migration inhibitory factor is important for the synthesis of il1β mRNA in vivo and in isolated macrophages. Altogether, macrophage migration inhibitory factor promotes neutrophil accumulation and is important for IL-1β production, which are 2 crucial events contributing to the pathogenesis of acute gout. © Society for Leukocyte Biology.

Entities:  

Keywords:  MIF; arthritis; chemokine; inflammasome

Mesh:

Substances:

Year:  2016        PMID: 26868525      PMCID: PMC4952013          DOI: 10.1189/jlb.3MA0915-418R

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  42 in total

1.  Macrophage migration inhibitory factor induces macrophage recruitment via CC chemokine ligand 2.

Authors:  Julia L Gregory; Eric F Morand; Sonja J McKeown; Jennifer A Ralph; Pamela Hall; Yuan H Yang; Shaun R McColl; Michael J Hickey
Journal:  J Immunol       Date:  2006-12-01       Impact factor: 5.422

2.  ISO-1 binding to the tautomerase active site of MIF inhibits its pro-inflammatory activity and increases survival in severe sepsis.

Authors:  Yousef Al-Abed; Darrin Dabideen; Bayan Aljabari; Aline Valster; Davorka Messmer; Mahendar Ochani; Mahira Tanovic; Kanta Ochani; Michael Bacher; Ferdinando Nicoletti; Christine Metz; Valentin A Pavlov; Edmund J Miller; Kevin J Tracey
Journal:  J Biol Chem       Date:  2005-08-22       Impact factor: 5.157

3.  MIF promotes B cell chemotaxis through the receptors CXCR4 and CD74 and ZAP-70 signaling.

Authors:  Christina Klasen; Kim Ohl; Marieke Sternkopf; Idit Shachar; Corinna Schmitz; Nicole Heussen; Elias Hobeika; Ella Levit-Zerdoun; Klaus Tenbrock; Michael Reth; Jürgen Bernhagen; Omar El Bounkari
Journal:  J Immunol       Date:  2014-04-23       Impact factor: 5.422

4.  Cytokine levels in human synovial fluid during the different stages of acute gout: role of transforming growth factor β1 in the resolution phase.

Authors:  Anna Scanu; Francesca Oliviero; Roberta Ramonda; Paola Frallonardo; Jean-Michel Dayer; Leonardo Punzi
Journal:  Ann Rheum Dis       Date:  2012-01-30       Impact factor: 19.103

5.  Cooperative role of tumour necrosis factor-α, interleukin-1β and neutrophils in a novel behavioural model that concomitantly demonstrates articular inflammation and hypernociception in mice.

Authors:  Daniela Sachs; Fernanda M Coelho; Vívian V Costa; Fernando Lopes; Vanessa Pinho; Flávio A Amaral; Tarcília A Silva; Antônio L Teixeira; Daniele G Souza; Mauro M Teixeira
Journal:  Br J Pharmacol       Date:  2011-01       Impact factor: 8.739

6.  Experimental arthritis triggers periodontal disease in mice: involvement of TNF-α and the oral Microbiota.

Authors:  Celso Martins Queiroz-Junior; Mila Fernandes Moreira Madeira; Fernanda Matos Coelho; Vivian Vasconcelos Costa; Rafaela Leal Costa Bessoni; Larissa Fonseca da Cunha Sousa; Gustavo Pompermaier Garlet; Danielle da Glória de Souza; Mauro Martins Teixeira; Tarcília Aparecida da Silva
Journal:  J Immunol       Date:  2011-09-02       Impact factor: 5.422

7.  Pro-inflammatory response resulting from sindbis virus infection of human macrophages: implications for the pathogenesis of viral arthritis.

Authors:  Iranaia Assunção-Miranda; Marcelo T Bozza; Andrea T Da Poian
Journal:  J Med Virol       Date:  2010-01       Impact factor: 2.327

Review 8.  Macrophage migration inhibitory factor: a key cytokine in RA, SLE and atherosclerosis.

Authors:  Leilani L Santos; Eric F Morand
Journal:  Clin Chim Acta       Date:  2008-09-21       Impact factor: 3.786

Review 9.  A concise history of gout and hyperuricemia and their treatment.

Authors:  George Nuki; Peter A Simkin
Journal:  Arthritis Res Ther       Date:  2006-04-12       Impact factor: 5.156

10.  The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor.

Authors:  T Calandra; J Bernhagen; R A Mitchell; R Bucala
Journal:  J Exp Med       Date:  1994-06-01       Impact factor: 14.307

View more
  15 in total

Review 1.  Macrophage migration inhibitory factor (MIF) as a therapeutic target for rheumatoid arthritis and systemic lupus erythematosus.

Authors:  Joshua B Bilsborrow; Edward Doherty; Pathricia V Tilstam; Richard Bucala
Journal:  Expert Opin Ther Targets       Date:  2019-08-20       Impact factor: 6.902

2.  CD300a contributes to the resolution of articular inflammation triggered by MSU crystals by controlling neutrophil apoptosis.

Authors:  Bruno V S Valiate; Celso M Queiroz-Junior; Francesca Levi-Schaffer; Izabela Galvão; Mauro M Teixeira
Journal:  Immunology       Date:  2021-06-06       Impact factor: 7.215

3.  Cynarin suppresses gouty arthritis induced by monosodium urate crystals.

Authors:  Changgui Wu; Shaohua Chen; Yang Liu; Bo Kong; Wei Yan; Tao Jiang; Hao Tian; Zhaoyi Liu; Qi Shi; Yongjun Wang; Qianqian Liang; Xiaobing Xi; Hao Xu
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

4.  Kinsenoside screening with a microfluidic chip attenuates gouty arthritis through inactivating NF-κB signaling in macrophages and protecting endothelial cells.

Authors:  Qiao Han; Wang Bing; Yin Di; Li Hua; Li Shi-He; Zheng Yu-Hua; Han Xiu-Guo; Wang Yu-Gang; Fan Qi-Ming; Yang Shih-Mo; Tang Ting-Ting
Journal:  Cell Death Dis       Date:  2016-09-01       Impact factor: 8.469

5.  Macrophage migration inhibitory factor is required for NLRP3 inflammasome activation.

Authors:  Tali Lang; Jacinta P W Lee; Kirstin Elgass; Anita A Pinar; Michelle D Tate; Elizabeth H Aitken; Huapeng Fan; Sarah J Creed; Nadia S Deen; Daouda A K Traore; Ivo Mueller; Danielle Stanisic; Francesca S Baiwog; Colin Skene; Matthew C J Wilce; Ashley Mansell; Eric F Morand; James Harris
Journal:  Nat Commun       Date:  2018-06-08       Impact factor: 14.919

6.  PD-1 mRNA expression in peripheral blood mononuclear cells as a biomarker for different stages of primary gouty arthritis.

Authors:  Jing Su; Xuefang Zhang; Qing Zhao; Zhaodi Guo; Jianxiong Wu; Guoqiang Chen; Qianxin Liang; Zhixiang Chen; Zhiliang He; Xiuping Cai; Manlin Xie; Lei Zheng; Kewei Zhao
Journal:  J Cell Mol Med       Date:  2020-07-08       Impact factor: 5.310

7.  Budlein A, a Sesquiterpene Lactone From Viguiera robusta, Alleviates Pain and Inflammation in a Model of Acute Gout Arthritis in Mice.

Authors:  Victor Fattori; Ana C Zarpelon; Larissa Staurengo-Ferrari; Sergio M Borghi; Tiago H Zaninelli; Fernando B Da Costa; Jose C Alves-Filho; Thiago M Cunha; Fernando Q Cunha; Rubia Casagrande; Nilton S Arakawa; Waldiceu A Verri
Journal:  Front Pharmacol       Date:  2018-09-25       Impact factor: 5.810

8.  A Randomized Controlled Trial of Chuanhutongfeng Mixture for the Treatment of Chronic Gouty Arthritis by Regulating miRNAs.

Authors:  Yao Wang; Liping Dong; Peng Liu; Ying Chen; Shaodan Jia; Yangang Wang
Journal:  Evid Based Complement Alternat Med       Date:  2019-02-03       Impact factor: 2.629

9.  Curcumin attenuates MSU crystal-induced inflammation by inhibiting the degradation of IκBα and blocking mitochondrial damage.

Authors:  Baofeng Chen; Hongmei Li; Guochun Ou; Long Ren; Xiaohong Yang; Mei Zeng
Journal:  Arthritis Res Ther       Date:  2019-08-27       Impact factor: 5.156

Review 10.  Modulating T Cell Responses via Autophagy: The Intrinsic Influence Controlling the Function of Both Antigen-Presenting Cells and T Cells.

Authors:  Seth D Merkley; Cameron J Chock; Xuexian O Yang; James Harris; Eliseo F Castillo
Journal:  Front Immunol       Date:  2018-12-14       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.